Jun 16, 2023
Tialma's Aleksey Krylov attending NewYorkBIO Life Science Company Showcase
Tialma's Aleksey Krylov to Attend NewYorkBIO Life Science Company Showcase
New York, NY, June 16, 2023 – Tialma, a CFO consultancy to the life science industry, is pleased to announce that Aleksey Krylov, Managing Director of Tialma, will be attending the highly anticipated NewYorkBIO Life Science Company Showcase, scheduled to take place on June 27, 2023.
The NewYorkBIO Life Science Company Showcase is an esteemed event that brings together influential leaders, investors, and stakeholders from the biotechnology and life science sectors. It serves as a platform for emerging companies to showcase their groundbreaking technologies, explore potential partnerships, and gain exposure to industry professionals and investors.
Aleksey Krylov, who has been instrumental in driving Tialma's contributions to life science industry, will be participating in the showcase virtually.
"I am delighted to be attending the NewYorkBIO Life Science Company Showcase," said Aleksey Krylov. "This event presents a remarkable opportunity for Tialma to connect with industry leaders, investors, and partners who share our commitment of advancing life sciences through cutting-edge technologies. We are to reconnect with old colleagues and make new contacts who make exciting impact on the field."
Tialma invites all attendees to visit Aleksey Krylov at the NewYorkBIO Life Science Company Showcase to learn more about how Tialma can support their organizations in achieving their strategic goals.
For media inquiries, please contact: Aleksey Krylov, firstname.lastname@example.org
Tialma is a New York-based Financial Consulting Firm that delivers bespoke Strategic CFO solutions to life sciences companies. Tialma professionals work with biotech, therapeutics, specialty pharma, diagnostics, medical devices, healthcare technology, and services organizations. The consultancy caters its solutions to the client’s needs to accelerate their next value inflection with fundraising, business development, and operating finance milestones that dramatically increase shareholder value.
Link to the press release: